The pharmaceutical landscape is seeing a shift with the arrival of GLP-1 transdermal systems . These innovative formulations offer a potential alternative to administering glucagon-like peptide-1 therapies https://charlieblxp712300.blog-gold.com/58018116/glp-1-patches-a-new-way-to-treat-diabetes